| scholarly article | Q13442814 |
| P2093 | author name string | Beyreuther K | |
| Multhaup G | |||
| Masters CL | |||
| Small DH | |||
| Moir RD | |||
| Pollwein P | |||
| Bush AI | |||
| Rumble B | |||
| Williamson TG | |||
| P433 | issue | 22 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Alzheimer's disease | Q11081 |
| P304 | page(s) | 16109-16112 | |
| P577 | publication date | 1993-08-01 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | A novel zinc(II) binding site modulates the function of the beta A4 amyloid protein precursor of Alzheimer's disease | |
| P478 | volume | 268 |
| Q33897528 | A potential role for alterations of zinc and zinc transport proteins in the progression of Alzheimer's disease |
| Q37996962 | A potential role for zinc alterations in the pathogenesis of Alzheimer's disease |
| Q37293809 | Abeta aggregation and possible implications in Alzheimer's disease pathogenesis |
| Q35220029 | Alterations of zinc transporter proteins ZnT-1, ZnT-4 and ZnT-6 in preclinical Alzheimer's disease brain |
| Q34761375 | Altered expression of ZnT10 in Alzheimer's disease brain |
| Q33906977 | Alzheimer's disease amyloid beta-protein forms Zn(2+)-sensitive, cation-selective channels across excised membrane patches from hypothalamic neurons |
| Q27694782 | Amyloid precursor protein dimerization and synaptogenic function depend on copper binding to the growth factor-like domain |
| Q26751302 | An overview on therapeutics attenuating amyloid β level in Alzheimer's disease: targeting neurotransmission, inflammation, oxidative stress and enhanced cholesterol levels |
| Q38263669 | Biometals and their therapeutic implications in Alzheimer's disease. |
| Q45020583 | Cholesterol, copper, and accumulation of thioflavine S-reactive Alzheimer's-like amyloid beta in rabbit brain |
| Q47973440 | Chronic exposure to high levels of zinc or copper has little effect on brain metal homeostasis or Abeta accumulation in transgenic APP-C100 mice |
| Q42995197 | Copper inhibits beta-amyloid production and stimulates the non-amyloidogenic pathway of amyloid-precursor-protein secretion |
| Q30498323 | Copper promotes the trafficking of the amyloid precursor protein |
| Q34479110 | Correlation of copper interaction, copper-driven aggregation, and copper-driven h(2)o(2) formation with aβ40 conformation |
| Q42723254 | Differential modulation of Alzheimer's disease amyloid beta-peptide accumulation by diverse classes of metal ligands. |
| Q28254726 | Disturbed copper bioavailability in Alzheimer's disease |
| Q42573332 | Effect of Metal Chelators on γ-Secretase Indicates That Calcium and Magnesium Ions Facilitate Cleavage of Alzheimer Amyloid Precursor Substrate |
| Q35941226 | Engineering metal ion coordination to regulate amyloid fibril assembly and toxicity |
| Q26852673 | Importance and management of micronutrient deficiencies in patients with Alzheimer's disease |
| Q33715870 | In vivo reduction of amyloid-beta by a mutant copper transporter |
| Q28070134 | Inhibitors of the Hydrolytic Enzyme Dimethylarginine Dimethylaminohydrolase (DDAH): Discovery, Synthesis and Development |
| Q26999922 | Insights into the physiological function of the β-amyloid precursor protein: beyond Alzheimer's disease |
| Q34347798 | Lowering of amyloid beta peptide production with a small molecule inhibitor of amyloid-β precursor protein dimerization |
| Q37412637 | Membrane-targeted strategies for modulating APP and Abeta-mediated toxicity. |
| Q37345733 | Metallomic Biomarkers in Cerebrospinal fluid and Serum in patients with Parkinson's disease in Indian population |
| Q28474584 | Metallomic profiling and linkage map analysis of early Parkinson's disease: a new insight to aluminum marker for the possible diagnosis |
| Q24643555 | Metals and amyloid-beta in Alzheimer's disease |
| Q33646882 | Metals and cholesterol: two sides of the same coin in Alzheimer's disease pathology |
| Q30620072 | Modulation of tau phosphorylation by environmental copper |
| Q53201006 | Modulation of the PC12 cell response to nerve growth factor by antisense oligonucleotide to amyloid precursor protein. |
| Q26744105 | Multi-Target Directed Donepezil-Like Ligands for Alzheimer's Disease |
| Q37799838 | Novel drug targets based on metallobiology of Alzheimer's disease. |
| Q41913198 | Novel zinc-binding site in the E2 domain regulates amyloid precursor-like protein 1 (APLP1) oligomerization. |
| Q33733571 | Oral zinc reduces amyloid burden in Tg2576 mice |
| Q37032450 | Palmitoylation of amyloid precursor protein regulates amyloidogenic processing in lipid rafts |
| Q39106565 | Some Biochemical Markers in Patients with Alzheimer's Disease |
| Q34384925 | Spatial memory deficits in a mouse model of late-onset Alzheimer's disease are caused by zinc supplementation and correlate with amyloid-beta levels |
| Q38961537 | Structure and Synaptic Function of Metal Binding to the Amyloid Precursor Protein and its Proteolytic Fragments |
| Q24600927 | Structure and biochemical analysis of the heparin-induced E1 dimer of the amyloid precursor protein |
| Q73107254 | The Alzheimer's disease amyloid precursor protein modulates copper-induced toxicity and oxidative stress in primary neuronal cultures |
| Q39095782 | The Metalloprotease Meprin β Is an Alternative β-Secretase of APP. |
| Q34063386 | The galvanization of beta-amyloid in Alzheimer's disease |
| Q41488419 | The role of zinc in Alzheimer's disease |
| Q37506739 | Trace copper levels in the drinking water, but not zinc or aluminum influence CNS Alzheimer-like pathology |
| Q35170198 | What can rodent models tell us about cognitive decline in Alzheimer's disease? |
| Q47371072 | Zinc Signal in Brain Diseases. |
| Q39016079 | Zinc and Copper Differentially Modulate Amyloid Precursor Protein Processing by γ-Secretase and Amyloid-β Peptide Production |
| Q33778362 | Zinc overload enhances APP cleavage and Aβ deposition in the Alzheimer mouse brain |
| Q37725035 | Zn2+ interaction with Alzheimer amyloid beta protein calcium channels |
Search more.